CLL: Transformation in Treatment
Join us as Ellin Berman, MD a leukemia expert from Memorial Sloan Kettering Cancer Center discusses the advancements in treatment for Chronic Lymphocytic Leukemia (CLL). Dr. Berman explains how not all CLL is the same, as it is a heterogeneous disease which explains why one person’s CLL can act differently from another person’s CLL. Dr. Berman speaks about how some patients do not start treatment right away and why some patients may be good candidates for clinical trials. Every patient is different, and since there are newer treatments now available for CLL, Dr. Berman provides patients with different treatment options, and encourages patients to ask questions and to be a partner with their treatment team when making treatment decisions.
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Chronic Lymphocytic Leukemia (CLL)
- Printable Question to ask your Doctor
- Memorial Sloan Kettering
- Clinical Trial Support Center (CTSC)
- Ibrutinib
Additional LLS Support Resources:
- Information Specialists
- Free telephone/web patient programs
- Free booklets
- Financial support
- Online chats
- Caregiver support
- LLS Community
- Support groups
- Patti Robinson Kaufmann First Connection Program
- Free Nutrition Consultations
Support for this episode provided by Pharmacyclics/Janssen.
The post CLL: Transformation in Treatment first appeared on The Bloodline with Blood Cancer United Podcast.